A case of vitamin B12 deficiency neurological syndrome in a young adult due to late-onset cobalamin C (CblC) deficiency: a diagnostic challenge.
cobalamin C
homocysteine
subacute combined degeneration
vitamin B12
Journal
Biochemia medica
ISSN: 1846-7482
Titre abrégé: Biochem Med (Zagreb)
Pays: Croatia
ID NLM: 9610305
Informations de publication
Date de publication:
15 Jun 2022
15 Jun 2022
Historique:
received:
05
01
2022
accepted:
24
02
2022
entrez:
25
4
2022
pubmed:
26
4
2022
medline:
27
4
2022
Statut:
ppublish
Résumé
Vitamin B12 deficiency can present with neurologic and psychiatric symptoms without macrocytic anaemia. We describe a case of late-onset cobalamin C deficiency which typically presents with normal serum vitamin B12 concentrations, posing an additional diagnostic challenge. A 23-year-old woman with decreased muscle strength and hallucinations was diagnosed with 'catatonic depression' and admitted to a residential mental health facility. She was referred to our hospital for further investigation 3 months later. Heteroanamnesis revealed that the symptoms had been evolving progressively over several months. Magnetic resonance imaging (MRI) of the brain showed diffuse symmetrical white matter lesions in both hemispheres. Routine laboratory tests including vitamin B12 and folic acid were normal except for a slight normocytic, normochromic anaemia. Over the next 6 weeks her symptoms deteriorated, and she became unresponsive to stimuli. A new MRI scan showed progression of the white matter lesions. The neurologist requested plasma homocysteine (Hcys) which was more than 8 times the upper limit of normal. Further testing revealed increased methylmalonic acid and the patient was diagnosed with adult-onset cobalamin C deficiency. This case illustrates that Hcys and/or methylmalonic acid should be determined in patients presenting with neuropsychiatric symptoms suggestive of vitamin B12 deficiency with a normal serum vitamin B12 to rule out a late-onset cobalamin C deficiency.
Identifiants
pubmed: 35464742
doi: 10.11613/BM.2022.020802
pii: bm-32-2-020802
pmc: PMC8996322
doi:
Substances chimiques
Methylmalonic Acid
8LL8S712J7
Folic Acid
935E97BOY8
Vitamin B 12
P6YC3EG204
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
020802Informations de copyright
Croatian Society of Medical Biochemistry and Laboratory Medicine.
Déclaration de conflit d'intérêts
Potential conflict of interest None declared.
Références
Nat Genet. 2006 Jan;38(1):93-100
pubmed: 16311595
J Inherit Metab Dis. 2017 Jan;40(1):21-48
pubmed: 27905001
Orphanet J Rare Dis. 2014 Nov 15;9:161
pubmed: 25398587
Med Clin North Am. 2019 Mar;103(2):383-397
pubmed: 30704689
N Engl J Med. 1988 Jun 30;318(26):1720-8
pubmed: 3374544
Medicine (Baltimore). 1991 Jul;70(4):229-45
pubmed: 1648656
Hum Mutat. 2009 Jul;30(7):1072-81
pubmed: 19370762
Neurology. 2009 Jan 6;72(1):e4
pubmed: 19122023
Neuropsychiatr Dis Treat. 2019 Feb 21;15:549-555
pubmed: 30863077
Eur J Pediatr. 1998 Apr;157 Suppl 2:S88-93
pubmed: 9587033
Nutrients. 2013 Nov 15;5(11):4521-39
pubmed: 24248213
Br J Haematol. 2014 Aug;166(4):496-513
pubmed: 24942828
BMC Nephrol. 2020 Mar 12;21(1):96
pubmed: 32164588
Metab Brain Dis. 2018 Jun;33(3):829-835
pubmed: 29374341
Mol Genet Metab. 2010 Feb;99(2):116-23
pubmed: 19836982
Zhonghua Er Ke Za Zhi. 2020 Jun 2;58(6):468-475
pubmed: 32521958
Nat Rev Dis Primers. 2017 Jun 29;3:17040
pubmed: 28660890
Front Mol Biosci. 2016 Jun 27;3:27
pubmed: 27446930